Di Vincenzo, Federica
 Distribuzione geografica
Continente #
NA - Nord America 2.146
AS - Asia 747
EU - Europa 579
SA - Sud America 206
Continente sconosciuto - Info sul continente non disponibili 45
AF - Africa 17
OC - Oceania 1
Totale 3.741
Nazione #
US - Stati Uniti d'America 2.049
SG - Singapore 279
IT - Italia 234
CN - Cina 178
BR - Brasile 156
VN - Vietnam 91
DE - Germania 67
FR - Francia 53
GB - Regno Unito 49
CA - Canada 48
FI - Finlandia 33
JP - Giappone 32
HK - Hong Kong 28
RU - Federazione Russa 28
BD - Bangladesh 25
SE - Svezia 25
KR - Corea 22
AR - Argentina 15
ID - Indonesia 15
IE - Irlanda 13
IL - Israele 13
IN - India 13
PL - Polonia 13
ES - Italia 11
IQ - Iraq 10
MX - Messico 10
CO - Colombia 8
EC - Ecuador 7
JM - Giamaica 7
NL - Olanda 7
CR - Costa Rica 5
LT - Lituania 5
NI - Nicaragua 5
VE - Venezuela 5
AT - Austria 4
CH - Svizzera 4
CL - Cile 4
GP - Guadalupe 4
SC - Seychelles 4
SV - El Salvador 4
UA - Ucraina 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
BE - Belgio 3
BY - Bielorussia 3
HN - Honduras 3
HR - Croazia 3
KE - Kenya 3
KG - Kirghizistan 3
NP - Nepal 3
OM - Oman 3
PK - Pakistan 3
PR - Porto Rico 3
PY - Paraguay 3
RO - Romania 3
SA - Arabia Saudita 3
TR - Turchia 3
UY - Uruguay 3
UZ - Uzbekistan 3
BB - Barbados 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GT - Guatemala 2
IR - Iran 2
KH - Cambogia 2
KZ - Kazakistan 2
MK - Macedonia 2
MT - Malta 2
PE - Perù 2
PH - Filippine 2
SI - Slovenia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AW - Aruba 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
JO - Giordania 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
PS - Palestinian Territory 1
RS - Serbia 1
SR - Suriname 1
TN - Tunisia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.696
Città #
San Jose 248
Ashburn 202
Singapore 158
Los Angeles 71
Rome 63
New York 54
Hefei 48
Council Bluffs 42
Dallas 40
Tokyo 31
Ho Chi Minh City 30
North Bergen 30
Hanoi 29
Beijing 28
Hong Kong 27
São Paulo 27
The Dalles 27
Lauterbourg 23
Boardman 22
Denver 22
Frankfurt am Main 22
Phoenix 21
Santa Clara 21
Seoul 21
Chicago 20
Atlanta 19
Munich 19
Montreal 16
Turku 14
Helsinki 13
Kent 13
London 12
Orem 12
San Francisco 12
Jakarta 11
Milan 10
Nuremberg 10
Brooklyn 9
Houston 9
Stockholm 9
Warsaw 9
Dublin 8
Düsseldorf 8
Poplar 8
St Louis 8
Toronto 8
Austin 7
Bologna 7
Rio de Janeiro 7
Boston 6
Lappeenranta 6
Philadelphia 6
Seattle 6
Tampa 6
Baghdad 5
Buffalo 5
Cagliari 5
Detroit 5
Florence 5
Managua 5
Manchester 5
Moscow 5
Newark 5
Salt Lake City 5
Bogotá 4
Brasília 4
Cincinnati 4
Cork 4
Elk Grove Village 4
Haiphong 4
Modena 4
Mumbai 4
Nanjing 4
Porto Alegre 4
Querétaro 4
San José 4
San Salvador 4
Tel Aviv 4
Vilnius 4
Athens 3
Baku 3
Baronissi 3
Bishkek 3
Brussels 3
Campinas 3
Columbus 3
Da Nang 3
Grazzanise 3
Guarulhos 3
Honolulu 3
Hyderabad 3
Montevideo 3
Nha Trang 3
Paris 3
Pittsburgh 3
Portsmouth 3
Roubaix 3
Secaucus 3
Tashkent 3
Turin 3
Totale 1.788
Nome #
Drug-Induced Acute Pancreatitis in Adults: Focus on Antimicrobial and Antiviral Drugs, a Narrative Review 481
Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases 313
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 275
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 257
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 167
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools 158
Endoscopic Management of Strictures in Crohn’s Disease: An Unsolved Case 149
Predictors of Efficacy of Janus Kinase Inhibitors in Patients Affected by Ulcerative Colitis 137
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 134
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 132
Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment 129
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 123
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 120
Psychopharmacological Therapy Positively Modulates Disease Activity in Inflammatory Bowel Disease: A Systematic Review 115
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 113
Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders 104
Parenteral Nutrition, Inflammatory Bowel Disease, and Gut Barrier: An Intricate Plot 103
Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases? 103
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies 96
The inflammatory bowel disease care manager: Italian state of the art 83
Intestinal-Failure-Associated Liver Disease: Beyond Parenteral Nutrition 53
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology 45
Neurofeedback as a non-pharmacological strategy for pain and gut-brain axis disorders: clinical relevance in inflammatory bowel disease 40
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weighting 39
Inflammatory bowel disease (IBD) is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity 39
Adverse Childhood Experiences and Disease Activity Are Associated with Post-Traumatic Stress Symptoms in Crohn’s Disease 39
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 36
Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study 36
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 35
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective Study 34
Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium Net 27
Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn's disease: A real- world latium net study 26
Totale 3.741
Categoria #
all - tutte 11.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202324 0 0 0 0 0 0 0 0 4 1 3 16
2023/2024140 4 8 7 2 3 16 4 3 20 12 21 40
2024/2025502 5 9 24 23 28 15 45 10 48 70 117 108
2025/20261.519 177 59 115 232 202 85 195 87 110 92 68 97
2026/20271.556 253 538 258 410 97 0 0 0 0 0 0 0
Totale 3.741